Production (Stage)
Applied Therapeutics, Inc.
APLT
$0.4099
-$0.0001-0.02%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 50.76M | 79.40M | 98.87M | 122.20M | 146.48M |
Total Receivables | -- | -- | 262.00K | 262.00K | 617.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.26M | 1.74M | 2.34M | 2.03M | 214.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1.95M | 2.51M | 3.14M | 3.08M | 3.59M |
Total Current Assets | 53.97M | 83.65M | 104.60M | 127.57M | 150.91M |
|
|||||
Total Current Assets | 53.97M | 83.65M | 104.60M | 127.57M | 150.91M |
Net Property, Plant & Equipment | 2.69M | 2.79M | 1.96M | 206.00K | 328.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 253.00K | 253.00K | -- | -- | -- |
Total Assets | 56.91M | 86.69M | 106.57M | 127.78M | 151.23M |
|
|||||
Total Accounts Payable | 4.87M | 4.43M | 2.84M | 2.68M | 4.02M |
Total Accrued Expenses | 8.81M | 15.33M | 12.72M | 9.06M | 12.77M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 426.00K | 406.00K | 264.00K | 185.00K | 308.00K |
Total Finance Division Other Current Liabilities | 3.86M | 7.13M | 83.15M | 43.43M | 66.81M |
Total Other Current Liabilities | 3.86M | 7.13M | 83.15M | 43.43M | 66.81M |
Total Current Liabilities | 17.97M | 27.30M | 98.97M | 55.36M | 83.91M |
|
|||||
Total Current Liabilities | 17.97M | 27.30M | 98.97M | 55.36M | 83.91M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 2.27M | 2.39M | 1.71M | 30.00K | 35.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 20.24M | 29.69M | 100.67M | 55.39M | 83.94M |
|
|||||
Common Stock & APIC | 632.70M | 631.22M | 624.11M | 622.02M | 619.82M |
Retained Earnings | -596.04M | -574.21M | -618.22M | -549.63M | -552.52M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 36.67M | 57.01M | 5.89M | 72.39M | 67.29M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 36.67M | 57.01M | 5.89M | 72.39M | 67.29M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 36.67M | 57.01M | 5.89M | 72.39M | 67.29M |
|